Cardiac Output, Low Clinical Trial
Official title:
Evaluation of the Impact of Ejection Fraction on Clinical Outcomes in Patients Undergoing Cardiovascular Surgery
This study evaluates the impact of ejection fraction (EF) on clinical outcomes in patients undergoing cardiovascular surgeries, specifically coronary artery bypass grafting (CABG) and heart valve replacement. It spans surgeries performed between 2012 and 2022 at Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital. Patients are categorized into two groups based on their preoperative EF: those with preserved EF (≥50%) and those with reduced EF (<50%). The primary aim is to assess how EF affects postoperative morbidity, mortality, hospital stay, and complications. Secondary aims include evaluating the development of postoperative arrhythmias, the need for vasopressors and inotropes, and transfusion requirements. Data will be collected retrospectively from hospital records and electronic health systems. The study's findings are expected to provide insights into tailored perioperative and postoperative management strategies for patients with varying EF levels, ultimately improving clinical outcomes.
Primary Objective The primary objective of this study is to evaluate the impact of ejection fraction (EF) on clinical outcomes in patients undergoing cardiovascular surgery. Specifically, the study aims to analyze the effects of EF on postoperative morbidity and mortality rates, length of hospital stay, and postoperative complications. Secondary Objectives Secondary objectives include assessing the development of arrhythmias in the postoperative period, the need for vasopressors and inotropes, and the requirement for transfusions. Scope of the Study Time Frame The study will encompass cardiovascular surgeries performed between 2012 and 2022. This time frame is selected to obtain a sufficient data set and evaluate long-term outcomes. Research Center The study will be conducted at Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital. Patient data from cardiovascular surgeries performed at this center will be analyzed. Patient Population The study will include all patients who underwent cardiovascular surgery within the specified time frame and had preoperative ejection fraction (EF) measurements. Study Design Group Formation Patients will be divided into two main groups based on their preoperative EF values: Preserved EF Group: Patients with an EF of 50 or above. Reduced EF Group: Patients with an EF below 50. Data to be Examined The following postoperative data will be examined and compared between the two groups: Development of Postoperative Arrhythmias: Whether patients develop arrhythmias in the postoperative period. Vasopressor Requirement: The need for vasopressors in the postoperative period. Inotrope Requirement: Whether patients require inotropic support postoperatively. Transfusion Requirement: The need for blood transfusions in the postoperative period. Mortality: Survival rates of patients following surgery. Need for Revision Surgery: Whether patients require additional surgical interventions postoperatively. Length of Stay in ICU: Duration of patients' stay in the intensive care unit. Total Hospital Stay: Overall length of hospital stay. Data Collection Method Data will be retrospectively collected from hospital records and electronic health record (EHR) systems. This structured approach aims to comprehensively evaluate the clinical outcomes of patients with varying levels of ejection fraction undergoing major cardiovascular surgeries, thereby providing insights that can enhance patient management strategies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05070819 -
Atrial Natriuretic Peptide in Assessing Fluid Status
|
N/A | |
| Recruiting |
NCT05492968 -
The Effect of Epinephrine, Norepinephrine and Phenylephrine on Intraoperative Hemodynamic Performance
|
Phase 4 | |
| Completed |
NCT03444545 -
Continous Cardiac Output - Non-Invasive Evaluation (CONNIE)
|
||
| Recruiting |
NCT04064177 -
Non-invasive Continuous Cardiac Output Monitoring in Preterm Infants Study
|
||
| Withdrawn |
NCT03058653 -
Use of a Mini-fluid Bolus to Identify Fluid Responsiveness
|
N/A | |
| Completed |
NCT02880683 -
Cardiac Output Autonomic Stimulation Therapy for Heart Failure (COAST-HF) - Human NeuroCatheter Study
|
N/A | |
| Recruiting |
NCT00989508 -
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
|
Phase 2/Phase 3 | |
| Completed |
NCT04955184 -
Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter
|
||
| Completed |
NCT02964663 -
Comparison of the Ability of the esCCO and the Volume View to Measure Trends in Cardiac Output During Cardiac Surgery
|
N/A | |
| Completed |
NCT04641949 -
Methoxyflurane and Fentanyl in LBNP
|
Phase 4 | |
| Recruiting |
NCT04191408 -
Predictive Ability of PEEP Induced Changes in CVP to Predict Volume Responsiveness in Mechanically Ventilated Patients After Major Abdominal Surgery
|
N/A | |
| Completed |
NCT01892696 -
Effects of Inspiratory Flow Waveforms on Preload
|
N/A | |
| Recruiting |
NCT02728791 -
Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution
|
N/A | |
| Completed |
NCT03930979 -
The Effect of Hyperoxia on Cardiac Output
|
||
| Recruiting |
NCT04755764 -
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy
|
||
| Enrolling by invitation |
NCT02702544 -
Effect of Passive Leg Raising for Fluid Responsiveness
|
N/A | |
| Completed |
NCT01880684 -
Validation of Capnography as a Predictor of Cardiac Output Change as Measured by FloTrac
|
Phase 2 | |
| Recruiting |
NCT05035719 -
Comparison Studies Comparing Hemodynamic Parameters Provided by the Caretaker Against Respective Gold Standard References
|
||
| Not yet recruiting |
NCT04774978 -
Real-time Continuous Cardiac Output Measurements
|
N/A | |
| Completed |
NCT02485782 -
Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis
|
N/A |